BRPI0808377B8 - composto, composição e uso de um composto - Google Patents
composto, composição e uso de um compostoInfo
- Publication number
- BRPI0808377B8 BRPI0808377B8 BRPI0808377A BRPI0808377A BRPI0808377B8 BR PI0808377 B8 BRPI0808377 B8 BR PI0808377B8 BR PI0808377 A BRPI0808377 A BR PI0808377A BR PI0808377 A BRPI0808377 A BR PI0808377A BR PI0808377 B8 BRPI0808377 B8 BR PI0808377B8
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- compounds
- methods
- composition
- metabolite
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 2
- 239000002207 metabolite Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 150000003953 γ-lactams Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88741507P | 2007-01-31 | 2007-01-31 | |
US60/887,415 | 2007-01-31 | ||
PCT/US2008/052318 WO2008094912A2 (en) | 2007-01-31 | 2008-01-29 | Substituted gamma lactams as therapeutic agents |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0808377A2 BRPI0808377A2 (pt) | 2014-07-08 |
BRPI0808377B1 BRPI0808377B1 (pt) | 2020-01-21 |
BRPI0808377B8 true BRPI0808377B8 (pt) | 2021-05-25 |
Family
ID=39639429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0808377A BRPI0808377B8 (pt) | 2007-01-31 | 2008-01-29 | composto, composição e uso de um composto |
Country Status (11)
Country | Link |
---|---|
US (1) | US7960381B2 (pt) |
EP (1) | EP2121672B1 (pt) |
JP (1) | JP5566692B2 (pt) |
KR (1) | KR101561706B1 (pt) |
CN (1) | CN101595106B (pt) |
AU (1) | AU2008210559B2 (pt) |
BR (1) | BRPI0808377B8 (pt) |
CA (1) | CA2676291C (pt) |
MX (1) | MX2009008039A (pt) |
NZ (1) | NZ578698A (pt) |
WO (1) | WO2008094912A2 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8377984B2 (en) * | 2008-01-29 | 2013-02-19 | Allergan, Inc. | Substituted gamma lactams as therapeutic agents |
AU2009239381A1 (en) * | 2008-04-24 | 2009-10-29 | Allergan, Inc. | Substituted gamma lactams as therapeutic agents |
AU2009239369B2 (en) | 2008-04-24 | 2014-03-06 | Allergan, Inc. | Substituted arylcyclopentenes as prostaglandin EP2 agonists |
BRPI0911347A2 (pt) * | 2008-04-24 | 2018-03-20 | Allergan Inc | gama lactamas substituídas como agentes terapêuticos |
JP2011520811A (ja) * | 2008-05-09 | 2011-07-21 | アラーガン インコーポレイテッド | 治療用の置換チアゾリジノン類、オキサゾリジノン類および関連化合物 |
AU2009249388B2 (en) * | 2008-05-20 | 2014-04-03 | Allergan, Inc. | Therapeutic lactams |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1409455B1 (en) * | 2001-07-16 | 2006-01-04 | F. Hoffmann-La Roche Ag | Prostaglandin analogues-as ep4 receptor agonists |
BR0213911A (pt) * | 2001-11-05 | 2004-09-28 | Allergan Inc | Análogos de Èmega-cicloalquil 17-heteroaril prostaglandina e2 como agonistas do receptor ep2 |
BR0308166A (pt) * | 2002-03-05 | 2005-01-18 | Ono Pharmaceutical Co | Compostos de derivados de 8-azaprostaglandina e drogas contendo os compostos como o ingrediente ativo |
US6573294B1 (en) * | 2002-05-14 | 2003-06-03 | Allergan, Inc. | 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
AU2003237520B2 (en) | 2002-06-10 | 2009-01-08 | Laboratoires Serono Sa | Gamma lactams as prostaglandin agonists and use thereof |
US7091231B2 (en) | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
EP1856042B1 (en) * | 2005-03-10 | 2012-06-27 | Allergan, Inc. | Substituted gamma lactams as therapeutic agents |
WO2007109578A2 (en) * | 2006-03-20 | 2007-09-27 | Allergan, Inc. | Substituted gamma lactams as prostaglandin ep2 agonists |
-
2008
- 2008-01-29 WO PCT/US2008/052318 patent/WO2008094912A2/en active Application Filing
- 2008-01-29 EP EP08728470.9A patent/EP2121672B1/en not_active Not-in-force
- 2008-01-29 CN CN200880003507.5A patent/CN101595106B/zh not_active Expired - Fee Related
- 2008-01-29 KR KR1020097017970A patent/KR101561706B1/ko active IP Right Grant
- 2008-01-29 AU AU2008210559A patent/AU2008210559B2/en not_active Ceased
- 2008-01-29 CA CA2676291A patent/CA2676291C/en not_active Expired - Fee Related
- 2008-01-29 JP JP2009548391A patent/JP5566692B2/ja not_active Expired - Fee Related
- 2008-01-29 US US12/524,803 patent/US7960381B2/en active Active
- 2008-01-29 BR BRPI0808377A patent/BRPI0808377B8/pt not_active IP Right Cessation
- 2008-01-29 NZ NZ578698A patent/NZ578698A/en not_active IP Right Cessation
- 2008-01-29 MX MX2009008039A patent/MX2009008039A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP2121672A2 (en) | 2009-11-25 |
AU2008210559A1 (en) | 2008-08-07 |
KR101561706B1 (ko) | 2015-10-19 |
CA2676291C (en) | 2017-11-28 |
CN101595106A (zh) | 2009-12-02 |
JP2010516817A (ja) | 2010-05-20 |
BRPI0808377A2 (pt) | 2014-07-08 |
CA2676291A1 (en) | 2008-08-07 |
MX2009008039A (es) | 2009-08-18 |
US7960381B2 (en) | 2011-06-14 |
US20100093729A1 (en) | 2010-04-15 |
EP2121672B1 (en) | 2014-12-10 |
JP5566692B2 (ja) | 2014-08-06 |
CN101595106B (zh) | 2014-05-07 |
KR20090104905A (ko) | 2009-10-06 |
BRPI0808377B1 (pt) | 2020-01-21 |
AU2008210559B2 (en) | 2014-03-06 |
WO2008094912A3 (en) | 2008-10-09 |
NZ578698A (en) | 2012-04-27 |
WO2008094912A2 (en) | 2008-08-07 |
WO2008094912B1 (en) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200714583A (en) | Substituted gamma lactams as therapeutic agents | |
BR122013025375B8 (pt) | compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas | |
EA201101672A1 (ru) | Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина | |
UY29963A1 (es) | Compuestos terapéuticos: piridinas y pirazinas como andamios | |
DE602006006712D1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
TN2009000180A1 (en) | NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF | |
ATE493386T1 (de) | Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate | |
ATE483707T1 (de) | 2-cyclopropylthiazolderivate | |
MX2009011997A (es) | Derivados de pirrolopirimidin-7-ona y su uso como farmaceuticos. | |
EA200971081A1 (ru) | Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7 | |
CR10327A (es) | "PIRIDIN(3-4-b) PIRAZINONAS" | |
UY30316A1 (es) | Derivados sustituidos de benzamidas, nicotinamidas, propanamidas, acetamidas y carboxamidas n-(2-(piperidin-1-ilmetil)ciclohexil)sustituidas, procesos de preparacion, composiciones conteniéndolos y aplicaciones | |
ECSP13012788A (es) | Derivados de biciclo[3,2,1]octilamida y sus usos | |
EA201101398A1 (ru) | Замещенные пиперидины в качестве антагонистов ccr3 | |
AR054347A1 (es) | Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
BRPI0821255A2 (pt) | Derivados de espiroindolinona | |
BRPI0714885B8 (pt) | compostos terapêuticos e seu uso | |
UY30393A1 (es) | Derivados sustituidos de la 1-piperidin-1-il-1,3-dihidro-2h-benzimidazol-2-ona, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones | |
ATE466842T1 (de) | 3-substituierte pyridinderivate als h3- antagonisten | |
MX2010002584A (es) | Derivados de piperidina como agonistas de receptores muscarinicos. | |
DOP2011000134A (es) | Lactamas como inhibidores de beta secretasa | |
BRPI0808377B8 (pt) | composto, composição e uso de um composto | |
ECSP088966A (es) | Agonistas del receptor muscarínico que son efectivos en el tratamiento del dolor, la enfermedad de alzheimer y la esquizofrenia | |
BR112012031340A2 (pt) | derivados de cianoquinolina | |
PH12015501386A1 (en) | Tricyclic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/01/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/01/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 15A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2707 DE 22-11-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |